ORI Capital is planning a US$350 million fund to focus on Chinese biotech, with hopes that AI will help beat the market.ORI Capital is planning a US$350 million fund to focus on Chinese biotech, with hopes that AI will help beat the market. Read More
Business – South China Morning Post
Boominance is a financial news and content aggregation platform that empowers people with top-tier financial information and resources. We deliver up-to-date market news, investment recommendations, and personal financial advice to help users make smarter investing, trading, and financial decisions.
